Literature DB >> 34388333

The effect of SARS-CoV-2 on the nervous system: a review of neurological impacts caused by human coronaviruses.

Colin Day1,2, Carson Studders3,2, Kim Arklie3,2, Asees Kaur3,2, Kyra Teetzen1,2, Rebecca Kirsch4, Laila Abelseth2, Ian Fraser3, Emily Abelseth1, Stephanie M Willerth3,2,5.   

Abstract

The COVID-19 pandemic has affected millions of people worldwide. While coronaviruses typically have low rates of neurotropic effects, the massive transmission of SARS-CoV-2 suggests that a substantial population will suffer from potential SARS-CoV-2-related neurological disorders. The rapid and recent emergence of SARS-CoV-2 means little research exists on its potential neurological effects. Here we analyze the effects of similar viruses to provide insight into the potential effects of SARS-CoV-2 on the nervous system and beyond. Seven coronavirus strains (HCoV-OC43, HCoV-HKU1, HCoV-229E, HCoV-NL63, SARS-CoV, MERS-CoV, SARS-CoV-2) can infect humans. Many of these strains cause neurological effects, such as headaches, dizziness, strokes, seizures, and critical illness polyneuropathy/myopathy. Certain studies have also linked coronaviruses with multiple sclerosis and extensive central nervous system injuries. Reviewing these studies provides insight into the anticipated effects for patients with SARS-CoV-2. This review will first describe the effects of other coronaviruses that have caused severe disease (SARS-CoV, MERS-CoV) on the nervous system, as well as their proposed origins, non-neurological effects, and neurological infection mechanisms. It will then discuss what is known about SARS-CoV-2 in these areas with reference to the aforementioned viruses, with the goal of providing a holistic picture of SARS-CoV-2.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Entities:  

Keywords:  central nervous system; infection; viruses

Mesh:

Year:  2021        PMID: 34388333      PMCID: PMC8997699          DOI: 10.1515/revneuro-2021-0041

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.703


  80 in total

1.  Inhaled nitric oxide to improve oxygenation for safe critical care transport of adults with severe hypoxemia.

Authors:  Nicholas R Teman; Jeffrey Thomas; Benjamin S Bryner; Carl F Haas; Jonathan W Haft; Pauline K Park; Mark J Lowell; Lena M Napolitano
Journal:  Am J Crit Care       Date:  2015-03       Impact factor: 2.228

2.  Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43.

Authors:  Mathieu Dubé; Alain Le Coupanec; Alan H M Wong; James M Rini; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

3.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Authors:  Aravinthan Varatharaj; Naomi Thomas; Mark A Ellul; Nicholas W S Davies; Thomas A Pollak; Elizabeth L Tenorio; Mustafa Sultan; Ava Easton; Gerome Breen; Michael Zandi; Jonathan P Coles; Hadi Manji; Rustam Al-Shahi Salman; David K Menon; Timothy R Nicholson; Laura A Benjamin; Alan Carson; Craig Smith; Martin R Turner; Tom Solomon; Rachel Kneen; Sarah L Pett; Ian Galea; Rhys H Thomas; Benedict D Michael
Journal:  Lancet Psychiatry       Date:  2020-06-25       Impact factor: 27.083

5.  Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital.

Authors:  X Wang; J Fang; Y Zhu; L Chen; F Ding; R Zhou; L Ge; F Wang; Q Chen; Y Zhang; Q Zhao
Journal:  Clin Microbiol Infect       Date:  2020-04-03       Impact factor: 8.067

6.  Seizure as the presenting symptom of COVID-19: A retrospective case series.

Authors:  Pria Anand; Abrar Al-Faraj; Elie Sader; Jonathan Dashkoff; Myriam Abdennadher; Rubachandran Murugesan; Anna M Cervantes-Arslanian; Ali Daneshmand
Journal:  Epilepsy Behav       Date:  2020-07-21       Impact factor: 2.937

Review 7.  COVID-19 virus may have neuroinvasive potential and cause neurological complications: a perspective review.

Authors:  Ali Sepehrinezhad; Ali Shahbazi; Sajad Sahab Negah
Journal:  J Neurovirol       Date:  2020-05-16       Impact factor: 2.643

8.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.

Authors:  Tao Chen; Di Wu; Huilong Chen; Weiming Yan; Danlei Yang; Guang Chen; Ke Ma; Dong Xu; Haijing Yu; Hongwu Wang; Tao Wang; Wei Guo; Jia Chen; Chen Ding; Xiaoping Zhang; Jiaquan Huang; Meifang Han; Shusheng Li; Xiaoping Luo; Jianping Zhao; Qin Ning
Journal:  BMJ       Date:  2020-03-26

Review 9.  Membrane binding proteins of coronaviruses.

Authors:  Entedar A J Alsaadi; Ian M Jones
Journal:  Future Virol       Date:  2019-04-29       Impact factor: 1.831

10.  High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.

Authors:  Hao Xu; Liang Zhong; Jiaxin Deng; Jiakuan Peng; Hongxia Dan; Xin Zeng; Taiwen Li; Qianming Chen
Journal:  Int J Oral Sci       Date:  2020-02-24       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.